Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma
Clinical trial NCT06485947 · RECRUITING
Trial details
- NCT number
- NCT06485947
- Sponsor
- Princess Maxima Center for Pediatric Oncology
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-28
- Primary completion
- 2030-07-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.